Basilea Pharmaceutica AG (SWX:BSLN)
52.80
+0.80 (1.54%)
At close: Mar 9, 2026
Basilea Pharmaceutica AG Employees
Basilea Pharmaceutica AG had 189 employees as of December 31, 2025. The number of employees increased by 25 or 15.24% compared to the previous year.
Employees
189
Change (1Y)
25
Growth (1Y)
15.24%
Revenue / Employee
1.23M CHF
Profits / Employee
212.91K CHF
Market Cap
649.00M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Newron Pharmaceuticals | 22 |
| Santhera Pharmaceuticals Holding AG | 79 |
| BioVersys AG | 29 |
| Molecular Partners AG | 153 |
| Xlife Sciences AG | 17 |
| Addex Therapeutics | 2 |
Basilea Pharmaceutica AG News
- 12 days ago - Basilea receives further USD 6 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam - GlobeNewsWire
- 20 days ago - Basilea Pharmaceutica Ltd (BPMUF) Full Year 2025 Earnings Call Highlights: Strong Revenue ... - GuruFocus
- 20 days ago - Full Year 2025 Basilea Pharmaceutica AG Allschwil Earnings Call Transcript - GuruFocus
- 20 days ago - Basilea reports strong 2025 full-year results, surpassing revenue and operating profit guidance - GlobeNewsWire
- 4 weeks ago - Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea - GlobeNewsWire
- 2 months ago - Basilea provides portfolio update and outlook - GlobeNewsWire
- 2 months ago - Prokaryotics and Basilea enter collaboration to develop a novel broad-spectrum antifungal for severe invasive infections - PRNewsWire
- 3 months ago - Basilea and Phare Bio enter partnership combining anti-infectives industry expertise with unique AI capabilities for the development of a novel antibiotic - GlobeNewsWire